Skip to main content
AstraZeneca Pharma India Ltd. logo

AstraZeneca Pharma India Ltd. — Investor Relations & Filings

Ticker · ASTRAZEN ISIN · INE203A01020 LEI · 335800N8M7W5JDTAHR68 BSE.NS Manufacturing
Open in API
Filings indexed 1,263 across all filing types
Latest filing 2023-01-14 Regulatory Filings
Country IN India
Listing BSE.NS ASTRAZEN

About AstraZeneca Pharma India Ltd.

https://www.astrazeneca.com/content/az-…

AstraZeneca Pharma India Ltd. is a science-led biopharmaceutical organization dedicated to the discovery, development, and commercialization of innovative prescription medicines. The company focuses on core therapeutic areas including Oncology, Cardiovascular, Renal & Metabolism, Respiratory & Immunology, and Rare Disease. Its product portfolio includes advanced treatments such as Tagrisso, Lynparza, and Imfinzi for various cancers, as well as Forxiga and Brilinta for metabolic and cardiovascular conditions. The company utilizes a robust global research pipeline to address complex medical challenges and improve patient outcomes. Through clinical research and specialized healthcare solutions, it delivers transformative therapies designed to treat chronic and life-threatening diseases. The organization is characterized by its commitment to scientific excellence and the delivery of high-value medical interventions.

Recent filings

Filing Released Lang Actions
We are enclosing herewith the Certificate dated January 2, 2023 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming ....
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, issued by the Registrar and Transfer Agents confirming compliance with dematerialization procedures for securities. It is addressed to stock exchanges and signed by the company secretary. The document is short (3235 characters) and primarily serves as a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or other report content. It is a regulatory compliance filing related to securities dematerialization and transfer agent activities, fitting best under Regulatory Filings (RNS).
2023-01-14 English
Closure of trading window
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about the closure of the trading window in compliance with insider trading regulations. It references the upcoming declaration of unaudited financial results but does not contain any financial data or the results themselves. The document is only 1272 characters long and serves as an announcement related to trading restrictions rather than a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-12-15 English
This is to inform you that, in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, read with AstraZeneca Pharma ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying the closure of the trading window in compliance with insider trading regulations. It mentions the trading window closure period related to the upcoming declaration of unaudited financial results for a specific quarter. The document is short (1272 characters) and serves as an announcement rather than containing any financial data or detailed report. It does not contain financial statements or management discussion, nor is it a report or transcript. This fits the category of a Regulatory Filing (RNS) as it is a compliance-related announcement that does not fit other specific categories.
2022-12-15 English
Appointment
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding changes in the company's board of directors and senior management. It details the resignation of the Managing Director and the appointment of a new Managing Director, including their profiles and effective dates. The document references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures about changes in directors or key managerial personnel. There is no financial data, earnings information, or report publication mentioned. The content clearly fits the category of announcements about board or management changes rather than financial reports or other filings.
2022-12-14 English
Resignation
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding changes in the company's board of directors and senior management. It details the resignation of the Managing Director and the appointment of a new Managing Director, including their profiles and effective dates. The document references compliance with SEBI regulations and includes annexures with detailed information about the changes. There is no financial data, earnings information, or report publication mentioned. This fits the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board or senior management.
2022-12-14 English
Based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company has approved the appointment of Mr. Sanjeev Panchal (DIN: 09823879), as Additional ....
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding changes in the company's board of directors and senior management. It details the resignation of the Managing Director and the appointment of a new Managing Director, including their profiles and effective dates. The document references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosure of events or information. There is no financial data, earnings information, or report publication mentioned. The content clearly fits the category of announcements related to changes in board or management personnel.
2022-12-14 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.